Repros Therapeutics Inc.

Quick facts

Marketed products

• AndroGel 1.62% · Endocrinology
  AndroGel 1.62% is a testosterone replacement therapy that restores physiological testosterone levels in hypogonadal men.
• Placebo Capsules
  Placebo capsules contain no active pharmaceutical ingredient and produce therapeutic effects primarily through the placebo effect.

Phase 3 pipeline

• Androxal · Other

Phase 2 pipeline

• Testim 1%

Phase 1 pipeline

• Androxal 25 mg
• Androxal 250 Capsules
• CYP1A2 probe
• CYP2C19 probe
• CYP2C9 probe
• CYP2D6 probe
• CYP3A4 probe
• Lucron Depot
• Proellex Formulation A
• Proellex Formulation B
• Progenta · Other

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Repros Therapeutics Inc. portfolio CI brief
• Repros Therapeutics Inc. pipeline updates RSS